Fact Sheets
To provide educational material to other medical professionals who care for patients with multiple sclerosis, the Cleveland Clinic Mellen Center for Multiple Sclerosis staff have developed the following series of professional "MS Approaches" information sheets. These documents are to be considered merely as educational, and individual physician judgement, knowledge, training and experience should always be utilized. Also, State and Federal regulations and guidelines may provide varying guidance in certain care situations.
Miscellaneous
- COVID-19: Considerations for Multiple Sclerosis Patients.
- Disability Benefits in Multiple Sclerosis.
- Management of Multiple Sclerosis During Pregnancy.
- Neurofilament Light Chain.
- Neuropsychological Assessment in Multiple Sclerosis and CNS Autoimmune Disorders.
- Optic Coherence Tomography (OCT) in the Diagnosis and Management of Multiple Sclerosis
- Pediatric-Onset Multiple Sclerosis
- PML Diagnosis and Management.
- Radiologically Isolated syndrome (RIS).
- Telehealth in MS and Neuroimmunology Care.
- The Role of MRI in the Diagnosis and Management of MS.
- Women’s Health in Myelin Oligodendrocyte Glycoprotein Antibody Disease
- Women’s Health in Neuromyelitis Optica Spectrum Disorder
MS Disease Modifying Therapy
- Alemtuzumab (Lemtrada).
- Dimethyl fumarate (Tecfidera).
- DMT Discontinuation.
- DMT Use in Progressive MS.
- Follow-On Disease Modifying Therapies.
- Ocrelizumab (Ocrevus).
- Ofatumumab.
- Oral Cladribine (Mavenclad).
- Ozanimod (Zeposia).
- Ponesimod (Ponvory).
- Safety Monitoring for Multiple Sclerosis Patients on Disease Modifying Therapies.
- Siponimod (Mayzent).
- Sphingosine 1-phosphate Receptor Modulators (Comprehensive).
- The Role of Stem Cell Therapy in Managing Multiple Sclerosis Patients.
MS Relapse Management
- Approaches to Diagnosis, Treatment and Management of Optic Neuritis.
- Considerations for the Administration of IVIG in MS Patients.
- Plasmapheresis in MS.
- Relapse Management in MS.
MS Symptom Management
- Behavioral Management of Anxiety and Depression in Multiple Sclerosis.
- Bladder Dysfunction in MS.
- Dalfampridine (Ampyra).
- Falls and Fall Prevention in MS.
- Fatigue in the Context of MS.
- Identifying and Managing Cognitive Disorders in MS.
- The Manifestations and Implications of Sexual Dysfunction in MS Patients.
- Understanding and Managing Pain in Multiple Sclerosis.
Other CNS Inflammatory Diseases
- Adult-onset Anti-NMDA Receptor Encephalitis.
- Diagnosis and Management of Autoimmune Encephalitis.
- Eculizumab (Soliris) for Neuromyelitis Optica Spectrum Disorder.
- Inebilizumab (Uplizna) for Neuromyelitis Optica Spectrum Disorder.
- Neuromyelitis Optica Spectrum Disorders.
- Satralizumab (Enspryng) for Neuromyelitis Optica Spectrum Disorder.
- Understanding Myelin Oligodendrocyte Antibody Disease.
Wellness and MS
- Augmenting MS Management with a Comprehensive Approach to Wellness and Comorbidity.
- Smoking and MS: Unraveling the Links, Impact on Disease Progression, and Cessation Strategies.
- The Role of Physical Exercise in Managing Multiple Sclerosis Symptoms.
- The Role of Wellness Consultations in the Management of Multiple Sclerosis.
- Understanding and Addressing Vitamin D Deficiency in MS.
- Vaccination Recommendations for Multiple Sclerosis Patients.
